Why is the incidence of side effects from statins so low in clinical trials but appear to be so high out in the real world? There is now overwhelming evidence to support reducing LDL cholesterol—bad cholesterol—to reduce atherosclerotic cardiovascular disease, the number one killer of men and women. So, why is adherence to cholesterol-lowering statin

Leave a Reply